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Abstract  Background/Objective:  Diseases  of  the  cardiovascular  system  and  depression  are
common,  and  they  often  coexist,  signiﬁcantly  deteriorating  the  quality  of  life.  Another  factor
inﬂuencing vital  functions  is  impairment  of  cognitive  functions  occurring  in  patients  with  heart
failure (HF).  Deﬁcits  of  different  degrees  of  severity  have  been  observed  within  a  variety  of
cognitive  domains.  Cognitive  deﬁcits,  which  may  impair  daily  functioning,  hinder  adaptation
to the  disease  and  worsen  prognosis,  are  also  observed  in  depression.  The  aim  of  this  study
was to  assess  the  relationship  between  the  quality  of  life,  the  severity  of  depressive  disorders
and disorders  of  certain  executive  functions,  and  memory  in  patients  with  severe,  stable  heart
failure. Method: The  study  group  consisted  of  50  patients  with  stable,  severe  heart  failure  and
50 appropriately  selected  patients  with  coronary  heart  disease,  without  heart  failure.  Results:
The results  of  cognitive  tests  are  signiﬁcantly  lower  in  the  HF  group  than  in  the  control  group.
In the  HF  group,  a  signiﬁcantly  lower  quality  of  life,  as  well  as  a  higher  result  in  the  BDI-II  test,
was observed.  No  inﬂuence  of  cognitive  disorders  on  the  reduction  in  the  quality  of  life  was
demonstrated.  The  factor  that  signiﬁcantly  affects  the  quality  of  life  is  the  intensiﬁcation  of
depression  symptoms.  Conclusions:  The  factor  that  signiﬁcantly  affects  the  quality  of  life  is  the
intensiﬁcation  of  depression  symptoms.
© 2016  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Published  by  Elsevier  Espan˜a,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
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Deterioro  cognitivo,  síntomas  depresivos  y  calidad  de  vida  relacionada  con  la  salud
en  pacientes  con  insuﬁciencia  cardiaca  estable  severa
Resumen  Antecedentes/Objetivo:  Las  enfermedades  cardiovasculares  y  la  depresión  son
comunes, y  muchas  veces  coexistentes,  empeorando  la  calidad  de  vida.  Además,  existen
trastornos  de  funciones  cognitivas  omnipresentes  en  pacientes  con  insuﬁciencia  cardiaca.  Se
observan deﬁciencias  de  distinto  nivel  de  severidad  en  varios  dominios  cognitivos.  Asimismo,
en la  depresión  existen  problemas  cognitivos  que  podrían  perjudicar  el  funcionamiento  cotid-
iano, obstaculizar  la  adaptación  a  la  enfermedad  y  empeorar  los  pronósticos.  El  objetivo  del
trabajo fue  evaluar  la  relación  entre  calidad  de  vida,  intensiﬁcación  de  trastornos  depresivos
y trastornos  de  ciertos  aspectos  de  las  funciones  ejecutivas  y  memoria  en  pacientes  con  insuﬁ-
ciencia cardiaca  grave  y  estable.  Método:  Los  estudios  se  realizaron  en  un  grupo  de  50  pacientes
con insuﬁciencia  cardiaca  grave  y  estable  y  otro  de  50  pacientes  con  enfermedad  coronaria,
pero sin  insuﬁciencia  cardiaca.  Resultados:  Los  resultados  de  las  pruebas  cognitivas  son  notable-
mente peores  en  el  grupo  con  insuﬁciencia  cardiaca  en  comparación  con  el  grupo  de  control.
Se observó  una  calidad  de  vida  considerablemente  peor  y  puntuaciones  signiﬁcativamente  más
altas en  el  BDI-II.  No  se  demostró  que  los  trastornos  cognitivos  inﬂuyeran  en  el  empeoramiento
de la  calidad  de  vida.  Sin  embargo,  se  observó  que  los  síntomas  de  depresión  inﬂuían  en  la
calidad de  vida.  Conclusiones:  El  factor  que  afecta  signiﬁcativamente  a  la  calidad  de  vida  es  la
intensiﬁcación  de  los  síntomas  depresivos.
© 2016  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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qTogether  with  the  development  of  medicine  and  its  diag-
nostic  and  therapeutic  possibilities,  life  expectancy  has
been  considerably  extended.  Nowadays,  effective  medical
intervention  enables  patients  to  survive  situations  that  once
inevitably  ended  in  death.  One  consequence  of  this  suc-
cess  in  medicine  is,  however,  an  increase  in  the  proportion
of  people  suffering  from  various  chronic  diseases  that  sig-
niﬁcantly  affect  their  quality  of  life.  Currently,  prevalent
lifestyle  diseases,  such  as  coronary  heart  disease  (CHD),
hypertension,  diabetes  and  depression,  considerably  limit
the  functioning  of  humans  and  hinder  their  adaptation  to
the  requirements  related  to  the  situation  of  the  disease
and  everyday  life  (Arrebola-Moreno  et  al.,  2014;  Granados-
Gámez,  Roales-Nieto,  Gil-Luciano,  Moreno-San  Pedro,  &
Márquez-Hernández,  2015).  The  diseases  interfere  with
functioning  on  many  levels:  physical,  social  and  emotional.
Cognitive  impairment  is  prevalent  in  heart  failure  (HF),
with  ranges  from  30-89%,  depending  on  the  type  of  mea-
surements  used  and  characteristics  of  the  studied  sample
(Stetkiewicz-Lewandowicz  &  Borkowska,  2013).  Cognitive
deﬁcits  in  patients  with  HF  are  often  subtle  and  difﬁcult  to
detect  with  standard  screening  instruments  (Pressler,  2008).
Studies  using  neuropsychological  instruments  indicate  that
deﬁcits  of  varying  severity  are  observed  in  several  cognitive
domains,  including  memory,  attention,  executive  function
and  psychomotor  speed.  These  deﬁcits  have  been  found
to  be  independent  of  age,  sex,  comorbidities,  alcohol  con-
sumption  and  education  level  (Pressler  et  al.,  2010a).  People
with  HF  have  a  more  than  four-fold  risk  of  cognitive  deﬁcits
compared  to  people  without  HF,  after  other  factors  such  as
age,  gender  and  comorbidities  have  been  taken  into  account
(Sauve,  Lewis,  Blankenbiller,  Rickabaugh,  &  Pressler,  2009).
Quite  often,  the  decline  does  not  cause  any  signiﬁcant  func-
tional  impairment,  and  thus  it  does  not  meet  the  criteria
a
t
bor  diagnosing  dementia.  It  is  deﬁned  as  mild  cognitive
mpairment  (MCI),  but  approx.  25%  of  patients  may  have
oderate-to-severe  cognitive  impairment  (CI)  (Kim,  Hwang,
him,  &  Jeong,  2015).
The  mechanisms  that  contribute  to  cognitive  deﬁcits  in
F  still  remain  unclear.  Studies  have  provided  evidence  that
he  clinically  detected  impairments  in  patients  with  HF  may
e  the  outcome  of  structural  or  neurodegenerative  changes
hich  cannot  be  reversed,  and/or  functional  neuronal  dys-
unctions  which  may  progress  to  neuronal  cell  death  or
mprove  in  response  to  treatment  (Dardiotis  et  al.,  2012).
erebral  and  systemic  haemodynamics  seem  to  inﬂuence
he  development  of  CI  in  patients  with  HF.  Cerebral  blood
ow  (CBF),  estimated  with  single-photon  emission  computed
omography  (SPECT),  was  reduced  by  about  30%  in  patients
ith  severe  HF  (NYHA  class  III/IV)  (Gruhn  et  al.,  2001),  and
ay  suggest  that  cognitive  performance  in  patients  with  HF
s  related  to  cerebral  perfusion.  Cerebral  perfusion  is  medi-
ted  by  a  number  of  factors,  including  cardiac  output  and
erebrovascular  reactivity  (Dardiotis  et  al.,  2012).  Another
spect  of  the  pathophysiology  of  cognitive  impairment  in  HF
s  the  development  of  cerebral  abnormalities  as  a  result  of
hronic  hypoperfusion  or  stroke  (Ampadu  &  Morley,  2015).
RI  studies  revealed  (Woo  et  al.,  2015) that  HF  patients  have
n  increased  frequency  of  focal  brain  abnormality,  ranging
rom  multiple  cortical  or  subcortical  infarcts  to  small  ves-
el  disease  with  white-matter  lesions  and  lacunar  infarcts,
ith  cerebral  embolism  and  hypoperfusion  being  the  most
lausible  mechanisms.
Depression  and  heart  disease  are  common,  and  they  fre-
uently  coexist,  often  worsening  both  the  quality  of  life
nd  prognosis  of  the  patient  due  to  poorer  adherence  to
reatment  (Muller,  Hess,  &  Hager,  2012).  The  relationship
etween  depression  and  heart  disease  is  multidimensional.
2 J.M.  Morys´ et  al.
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Table  1  Clinical  characteristics  of  patients  with  severe  HF.
NYHA  II  III
39%  61%
Yes  No
CHD  56%  44%
Diabetes  meatus  37%  63%
Hypertension  32%  68%
Mean  SD  Min  Max
LVEF 18  5  10  30
creatinine  1.12 0.3 0.6 1.8
VO2max 9.8 2.7 6  15
6MWT 296  91  150  503
Note. NYHA: New York Heart Association Functional Classiﬁ-
cation; CHD: coronary heart disease; LVEF: Left Ventricular
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epression  is  associated  with  several  physiological  derange-
ents  that  could  contribute  to  adverse  cardiac  outcomes.
atients  with  depression  have  high  sympathetic  tone,
ypercortisolemia,  elevated  catecholamine  levels,  abnor-
al  platelet  activation,  increased  inﬂammatory  markers
nd  endothelial  dysfunction  (Rumsfeld  &  Ho,  2005),  which
urther  increase  the  risk  of  coronary  events.  Addition-
lly,  subjectively  experienced  problems  with  concentration,
emory,  problem  solving  and  thinking  occur  and  are  likely
o  impair  daily  functioning  (Evans,  Iverson,  Yatham,  &  Lam,
014;  Iverson  &  Lam,  2013).
There  is  compelling  evidence  that  depression  is  the  best
redictor  of  quality  of  life  in  patients  with  CHD,  both  in
hort-  and  long-term  CHD.  While  the  relationship  between
epression  and  coronary  heart  disease  has  been  extensively
esearched  over  the  years,  it  is  the  role  of  health-related
uality  of  life  in  this  relationship  that  has  recently  become
f  interest.  Patients  with  CHD  experience  numerous  symp-
oms,  including  fatigue,  dyspnoea,  stenocardia  and  oedema,
nd  it  is  important  to  assess  how  the  disease  impacts  the
atient’s  physical,  emotional  and  social  well-being.  It  is
nown  that  a  low  quality  of  life  decreases  the  patient’s  moti-
ation  to  adhere  to  recommendations,  which  is  conducive  to
epression  and  signiﬁcantly  worsens  the  prognosis  (Ubiegło,
chmanowicz,  Wleklik,  Jankowka-Polan´ska,  &  Kus´mierz,
015).
The  main  objective  of  the  study  was  to  assess  the  rela-
ionship  between  the  quality  of  life,  severity  of  depressive
isorders,  and  memory  impairment,  as  well  as  some  aspects
f  the  executive  functions  in  patients  listed  for  elective
eart  transplant.  The  study  was  conducted  in  a  very  spe-
iﬁc  and  rare  group  of  patients.  These  were  patients  with
xtreme  but  stable  heart  failure  and  without  any  other
evere  comorbidities  or  multiple  organ  inefﬁciency,  which
ften  occurs  in  patients  with  heart  failure.  Another  objec-
ive  was  to  assess  cognitive  impairment  patterns  in  this
roup  of  patients.
ethod
articipants
he  convenience  cohort  study  consisted  of  50  patients  with
evere  heart  failure  (age  range:  34-68  years)  among  patients
isted  for  elective  heart  transplant  (HTx),  recruited  from  the
linical  Cardiology  Centre,  and  50  age-,  gender-  and  level
f  education-  matched  volunteers  (age  range:  43-68  years)
ith  stable  coronary  artery  disease  without  HF,  recruited
rom  the  Department  of  Rehabilitation  and  Department
f  Cardiology  and  Cardiac  Rehabilitation  of  the  University
linical  Centre  in  Gdan´sk.  The  study  group  consisted  of
ighly-selected  patients  who  met  the  procedure  HTx  eligi-
ility  criteria,  which  means  no  multiple  organ  inefﬁciency  or
evere  comorbidities  such  as  poorly  controlled/uncontrolled
iabetes.  All  consecutive  patients  eligible  for  HTx  proce-
ures  were  included  in  the  study.  The  clinical  characteristics
f  patients  with  HF  are  presented  in  Table  1.The  average  age  of  the  HF  subjects  (42  males  and  8
emales)  was  56  years  (SD  =  8),  and  the  average  age  for  the
ontrol  group  (44  males  and  6  females)  was  also  56  years
SD  =  9).  The  differences  in  the  mean  ages  and  gender  ofEjection Fraction; VO2max: maximal oxygen uptake; 6MWT: 6-
minute walk test.
he  examined  and  control  groups  were  found  to  be  statis-
ically  insigniﬁcant.  The  study  group  included  patients  with
eart  failure  (EF  <20%)  who  achieved  at  least  24  points  in  the
MSE,  were  able  to  understand  questions/tasks,  and  agreed
o  participate  in  the  study.  The  following  were  excluded
rom  participation  in  the  study:  people  with  a  diagnosis  of
 major  depressive  disorder,  history  of  an  affective  disorder
r  schizophrenia,  disorders  of  cerebral  circulation,  cranio-
erebral  trauma,  renal  insufﬁciency,  alcoholism,  Parkinson’s
isease,  Alzheimer’s  disease,  epilepsy,  disorders  of  con-
ciousness,  and  serious  somatic  disorders,  especially  during
ecompensation.  The  control  group  included  patients  with-
ut  heart  failure,  with  stable  coronary  artery  disease  found
y  angiography,  and  with  no  apparent  abnormalities  which
re  indicated  for  exclusion  from  the  HF  group.
rocedure
he  study  was  conducted  from  01  January  2013  to  31
arch  2015.  The  study  protocol  included  medical  history
Table  1),  assessment  of  cognitive  functions,  quality  of
ife  (MacNew  questionnaire)  and  screening  for  depression
Beck  Depression  Inventory-II,  BDI-II).  Each  patient  under-
ent  a  psychiatric  examination.  Patients  diagnosed  with
ental  disorders  were  excluded  from  subsequent  studies.
he  Medical  Ethics  Committee  of  the  Medical  University  of
dan´sk  approved  the  study  protocols  (NKEBN/180/2013).
pon  entering  the  study,  each  participant  gave  his  or  her
nformed  consent.
easures
 Assessment  of  HRQL.  Group  differences  in  perception  of
quality  of  life  were  determined  by  an  analysis  based  on
the  MacNew  health-related  quality  of  life  questionnaire
(MacNew  HRQL)  (Lim  et  al.,  1993).  This  was  designed
to  assess  cardiac  patients’  feelings  concerning  how  their
daily  functioning  is  affected  by  heart  disease.  The  ques-
tionnaire  contains  27  items  with  a  global  HRQL  score,
and  physical,  emotional  and  social  subscales.  The  MacNew
questionnaire  has  a  2-week  timeframe  to  assess  a  patient’s
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Table  2  Descriptive  statistics  of  the  cognitive  performance  and  the  symptoms  of  depression  in  the  HF  and  cardiac  control
groups.
Age  [year] HF  group  Cardiac  control t Cohen  d  p  -  value
M  SD  M  SD
56.02  7.70  56.02  9.29  0.11  0.02  ns
MMSE 27.86  1.47  29.44  0.61  7.15  1.44  <  .001
BDI-II 17.00 9.80  4.36  2.69  -8.66  -1.75  <  .001
COWAT k  -  letter 12.24 4.29 16.88  3.98  5.61  1.13  <  .001
COWAT animals 17.61 4.37 24.66 4.36 8.10 1.64  <  .001
COWAT m  -  letter  &  supermarket 6.73 2.16 10.60 1.31 10.69 2.16 <  .001
Digit span  forward  (WAIS--R)  5.35  1.65  7.18  2.47  4.43  0.89  <  .001
Digit span  backward  (WAIS-R)  4.14  1.15  4.98  1.71  2.82  0.57  ns
CTT1 [seconds]  75.45  30.12  52.78  13.26  -4.87  -0.98  <  .001
CTT2 [seconds]  152.10  57.53  101.32  13.50  -6.12  -1.24  <  .001
Spatial span  forward  (WMS--III) 6.98 1.83 7.88 1.41  2.80  0.58  ns
Spatial span  backward  (WMS--III) 5.89 1.79 7.02 0.96 3.93  0.81  <  .001
Logic memory  I  recall  (WMS--III) 32.33 8.32 42.72 4.15 7.44  1.53  <  .001
Logic memory  II  recall  (WMS--III)  17.96  6.15  27.60  4.30  7.05  1.45  <  .001
Logic memory  II  recognition  (WMS--III)  23.26  3.34  25.74  1.48  4.73  0.97  <  .001
Logic memory  II  %  retention  (WMS--III)  75.13  13.94  92.64  4.19  8.49  1.74  <  .001
CVLT -  TL  44.04  7.79  51.88  4.17  6.18  1.26  <  .001
CVLT -  SDFR  9.04  2.85  12.22  1.73  6.62  1.35  <  .001
CVLT -  SDCR  10.83  2.28  13.55  1.47  6.98  1.43  <  .001
CVLT -  LDFR  9.23  2.98  13.47  1.79  8.42  1.72  <  .001
CVLT -  LDCR  10.89  2.38  14.49  1.51  8.91  1.82  <  .001
CVLT -  recognition  14.42  1.41  15.33  0.80  3.78  0.77  <  .001
MacNew Global  4.20  0.87  6.22  0.42  14.65  2.99  <  .001
MacNew Physical  3.71  0.99  6.16  0.47  15.65  3.20  <  .001
MacNew Emotional  4.67  0.96  6.08  0.43  9.17  1.87  <  .001
MacNew Social  4.09  0.96  6.27  0.46  14.47  2.95  <  .001
Note. MMSE: Mini--Mental State Examination; BDI-II: Beck Depression Inventory; COWAT: Controlled Oral Word Association Test; WAIS-R:
Wechsler Adult Intelligence Scale--Revised; CTT 1 & 2: Color Trails Test; WMS-III: Wechsler Memory Scale III; CVLT: California Verbal
ed re
-Learning Test; SDFR: Short-delay free recall; SDCR: Short-delay cu
feelings  about  daily  functioning,  with  each  item  scored
from  1  (low  HRQL)  to  7  (high  HRQL).  In  our  study  we  used
a  Polish  version  of  the  MacNew  questionnaire,  validated  in
a  cardiac  cohort  by  Morys´, Höfer,  Rynkiewicz,  &  Oldridge
(2015).
-  Neuropsychological  assessment.  The  Mini-Mental  State
Examination  (MMSE)  is  effective  as  a  screening  tool  for
cognitive  impairment,  and  it  tests  ﬁve  areas  of  cognitive
function:  orientation,  registration,  attention  and  calcula-
tion,  recall  and  language  (Folstein,  Folstein,  &  McHugh,
1975).  In  our  study,  we  used  a  Polish  version  drawn  up
by  Stan´czak  (Folstein,  Folstein,  &  Fanjiang,  2009).  Ver-
bal  ﬂuency  was  tested  with  the  use  of  the  Controlled  Oral
Word  Association  Test  (COWAT)  (Benton,  Hamsher,  &  Sivan,
1983).  The  task  was  to  list,  within  60  seconds,  as  many
words  beginning  with  the  letter  ‘‘k’’,  and  animals  and
objects  beginning  with  the  letter  ‘‘m’’  that  can  be  bought
in  a  supermarket.  The  digit  span  test  from  the  Wech-
sler  Adult  Intelligence  Scale  (WAIS-R,  PL)  served  to  test
attention  span  and  reversing  operation  (mental  double-
tracking)  (Brzezin´ski  et  al.,  2004;  Wechsler,  1981).  The
Color  Trails  Test  (CTT)  (D’Elia,  Satz,  Uchiyama,  &  White,
1996;  Łojek  &  Stan´czak,  2012)  was  used  for  the  evaluationcall; LDFD: Long-delay free recall; LDCD: Long-delay cued recall.
of  attention,  visual  search  and  scanning,  sequencing  and
shifting,  psychomotor  speed,  and  the  ability  to  maintain
two  trains  of  thought  simultaneously  (executive  func-
tions).  The  spatial  span  from  the  Wechsler  Memory  Scale
-  III  (WMS-III)  was  used  as  an  indicator  of  working  mem-
ory  and  visuospatial  processing,  while  Logical  Memory  (LM)
was  used  to  assess  short-  and  long-term  organised  verbal
memory  (Wechsler,  1997).  The  California  Verbal  Learning
Test  (CVLT)  (Delis,  Kramer,  Kaplan,  &  Ober,  1987;  Łojek  &
Stan´czak,  2010) served  to  measure  verbal  learning  abili-
ties  and  memory.
 Evaluation  of  depressive  symptoms.  BDI-II  is  the  gold
standard  of  self-rating  scales,  designed  to  measure  the
severity  of  symptoms  of  depression  in  patients  experi-
enced  in  the  past  two  weeks  (Beck,  Ward,  Mendelson,
Mock,  &  Erbaugh,  1961).  In  screening,  a  total  score  of  14
or  higher  is  the  most  widely  used  cut-off  for  clinically  sig-
niﬁcant  depression.  The  following  guidelines  have  been
suggested  to  interpret  BDI-II:  scores  of  0  to  13  indicate  no
depression,  14  to  19  mild  depression,  20  to  28  moderate
depression  and  29  to  63  indicate  severe  depression.  In  our
study,  we  used  a  Polish  version  of  the  BDI  drawn  up  by
Parnowski  and  Jernajczyk  (1977).
2 J.M.  Morys´ et  al.
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Table  3  The  relationship  between  the  assessment  of  the
quality of  life  and  level  of  cognitive  performance,  as  well  as
the symptoms  of  depression.
Quality  of  life  -  global
HF  group Cardiac
control
group
MMSE  -.07  .11
BDI-II -.47*  -.22*
COWAT  k  -  letter .09 -.38*
COWAT  animals -.07 -.18
COWAT  m  -  letter  &
supermarket
.15 -.31*
Digit  span  forward  (WAIS--R)  .22  -.14
Digit span  backward  (WAIS--R)  .11  -.08
CTT1 [seconds] -.14  .11
CTT2 [seconds] .00  .29*
Spatial span  forward  (WMS--III) .16 -.04
Spatial  span  backward
(WMS--III)
.15  -.07
Logic memory  I recall  (WMS--III) .13 .13
Logic  memory  II  recall
(WMS--III)
.12 -.15
Logic  memory  II  recognition
(WMS-III)
.09  .04
Logic memory  II  %  retention
(WMS--III)
-.03  -.09
CVLT -  total  learning  .27  .16
CVLT -  SDFR  .11  .07
CVLT -  SDCR  .20  .06
CVLT -  LDFR  .21  .12
CVLT -  LDCR  .19  .19
CVLT -  recognition  .18  .09
Note. Correlation coefﬁcient (95% correlations limits, * p< .05).
MMSE: Mini--Mental State Examination; BDI-II: Beck Depres-
sion Inventory; COWAT: Controlled Oral Word Association Test;
WAIS--R: Wechsler Adult Intelligence Scale--Revised; CTT 1 &
2: Color Trails Test; WMS-III: Wechsler Memory Scale III; CVLT:
California Verbal Learning Test; SDFR: Short-delay free recall;
SDCR: Short-delay cued recall; LDFD: Long-delay free recall;
LDCR: Long-delay cued recall.
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tatistical  analysis
ll  results  are  reported  as  mean  ±  standard  deviation  (SD)
or  continuous  variables.  Distribution  of  continuous  varia-
les  was  assessed  in  terms  of  its  compliance  with  normal
istribution  using  the  Kolmogorov-Smirnov  test.  Statistical
igniﬁcance  of  differences  between  the  means  of  continu-
us  variables  with  normal  distribution  were  evaluated  using
tudent’s  t  test,  and  the  average  distributed  variables  differ-
nt  from  the  normal  Mann-Whitney  U  test.  To  determine  the
orrelation  between  the  different  parameters,  the  Spear-
an  correlation  index  (r)  was  used.  Values  of  p  <  .05  were
onsidered  statistically  signiﬁcant.  Statistical  calculations
ere  performed  using  the  commercial  statistical  package
TATISTICA  (data  analysis  software  system),  version  10,  by
tatSoft,  Inc.  (2011)  Tulsa,  United  States.
esults
ognitive  performance  in  the  HF  group  was  signiﬁcantly
ower  than  in  the  cardiac  control  group  (Table  2).  Poorer
esults  were  observed  both  during  the  general  screening
MMSE)  and  in  almost  all  the  tests.  Only  in  the  case  of  digit
pan  backward  and  spatial  span  forward  was  there  no  sta-
istically  signiﬁcant  difference  between  the  HF  and  cardiac
ontrol  groups.
Statistical  signiﬁcance  was  obtained  between  the  exam-
ned  groups  in  their  perceptions  of  quality  of  life  as
valuated  by  the  MacNew  global  scale  and  each  subscale
Table  2).  In  the  HF  patients,  the  best  results  were  obtained
n  the  MacNew  emotional  subscale,  while  the  lowest  rating
as  obtained  on  the  subscale  assessing  physical  limitations.
n  contrast,  the  cardiac  control  group  assessed  the  highest
ocial  HRQL  and  the  lowest  emotional  HRQL.
Despite  the  fact  that  patients  with  diagnosed  depression
ere  excluded  from  the  study,  mean  scores  in  the  BDI-II
ere  signiﬁcantly  higher  than  in  the  cardiac  control  group
Table  2).  The  average  result  in  the  HF  group  was  17.00
oints  (SD  =  9.8),  whereas  in  the  cardiac  control  group,  this
as  4.36  points  (SD  =  2.69).
Analysis  of  the  factors  that  affected  an  assessment  of  the
uality  of  life  showed  differences  between  the  HF  group  and
he  cardiac  control  group.  Evaluation  of  the  global  quality
f  life  in  the  HF  group  correlates  negatively  only  with  results
btained  on  the  BDI-II  scale  (Table  3).  Linear  regressions  are
resented  in  Figure  1.
In  the  control  group,  global  quality  of  life  was  associ-
ted  with  more  factors.  There  was  a  negative  correlation
etween  global  MacNew  and  BDI-II,  as  well  as  COWAT  (k-
etter),  and  a  positive  correlation  with  the  results  of  CTT2
Table  3).  Linear  regressions  are  presented  in  Figure  2.
Analysis  of  the  relationship  between  the  results  on  the
epression  scale  various  dimensions  of  quality  of  life  and
esults  of  the  symptoms  of  depression,  as  well  as  cognitive
ests,  also  showed  differences  between  the  HF  group  and
he  cardiac  control  group  (Table  4).  In  the  HF  group,  a
egative  correlation  was  observed  between  the  results  of
DI-II  and  all  subscales  of  MacNew.  In  this  group  there  was
o  relationship  between  the  quality  of  life  for  both  global
erformance  as  well  as  various  dimensions  of  quality  of  life
nd  cognitive  performance  (Tables  3  and  4).  In  the  cardiac
MNGlob
Figure  1  The  linear  regressions  of  BDI-II  and  MNGlobal  in  the
HF group.
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Table  4  Analysis  of  the  relationship  between  the  various  dimensions  of  quality  of  life  and  results  of  the  symptoms  of  depression,
as well  as  cognitive  tests  in  the  HF  group  and  in  the  cardiac  control  group.
HF  group  Cardiac  control  group
MNPh  MNEm  MNSc  MNPh  MNEm  MNSc
MMSE  -.01  -.08  -.05  .14  .00  .05
BDI-II -.29* -.56*** -.44*** -.16  -.13  .33*
COWAT  K -.00 .11  .05  -.23  -.18  -.29*
COWAT Z -.10 -.03 -.16  -.17  -.35* -.12
COWAT M .04 .22 .07 -.42*** -.40*** -.25
Digit Span forward .17 .19 .10 .12 .12 -.17
Digit  Span  backward  .04  .16  .03  .10  .02  -.17
CTT1 -.11  -.12  -.01  .11  .07  .17
CTT2 .04  -.04  .09  .37** .25  .30*
Spatial  span  -forward  .17  .11  -.00  .00  -.10  .03
Spatial span  -backward .09 .17 .06 .02  .16  -.14
LM I  -  Recall -.01 .26 .10 .08 -.04  -.13
LM II  -  Recall -.12 -.04 -.11 -.02 -.05  -.04
LM II  -  Recognition  .04  .10  .10  .28* .14  .11
LM II  -  Retention  [%]  -.19  .12  -.13  .07  -.09  -.04
CVLT-TL .22  .26  .21  .06  .03  .02
CVLT-SDFR .12  .10  .07  .07  .05  .08
CVLT-SDCR .15  .20  .15  -.04  -.00  .10
CVLT-LDFR .14  .25  .13  .13  .01  .17
CVLT-LDCR .15  .19  .10  .05  .12  .13
CVLT-recognition  .17  .12  .18  .10  .06  .05
Note.
* p < .05.
** p < .01.
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control  group  we  found  a  correlation  between  the  results
for  BDI-II  and  only  one  dimension  of  quality  of  life--the  social
subscale  of  quality  of  life.  In  this  group  of  patients  the  rela-
tionship  between  the  physical  as  well  as  emotional  (but  not
social)  dimensions  of  the  quality  of  life  and  COWAT-M  was
observed.  The  social  dimension  correlated  with  COWAT-K.
Furthermore,  we  found  a  relationship  between  CTT2  and
the  physical  as  well  as  social  dimensions  of  quality  of  life.
There  was  also  a  relationship  between  physical  QoL  and
recognition  in  the  logical  memory  test  of  WMS-III  (Table  4).
The  BDI-II  correlation  analysis  with  other  results  has
shown  that  in  addition  to  a  negative  correlation  with  the
scales  of  evaluating  various  aspects  of  quality  of  life,  there
is  also  a  negative  correlation  between  the  BDI-II  and  LM-I
Recall  Total  Score  (Table  5).
Discussion
In  the  1970s  heart  failure  was  proposed  as  a  possi-
ble  cause  of  cognitive  dysfunction.  Soon  afterwards,  the
term  ‘‘cardiogenic  dementia’’  appeared.  Subsequently,  the
results  of  numerous  studies  suggested  that  decreased  heart
function,  as  measured  by  indices  of  low  cardiac  output,  was
independently  associated  with  impairment  in  various  cog-
nitive  domains  (Almeida  et  al.,  2012).  These  deﬁcits  are
greater  than  those  normally  attributed  to  the  normal  ageing
process.  There  are  no  other  symptoms  of  dementia,  such  as
t
g
H
tmpaired  judgment  or  reasoning,  or  difﬁculties  performing
ctivities  of  daily  life.  Dementia  usually  represents  a  tran-
itional  state  between  the  cognitive  changes  of  ageing  and
he  earliest  clinical  manifestations  of  dementia  (Nordlund,
erggren,  Holmstrom,  Fu,  &  Wallin,  2015).  Because  of  the
eterogeneity  of  HF  patients,  where  a  variety  of  vascular
isk  factors  and  co-morbidity  contribute  to  the  development
f  cognitive  decline,  widely  varied  patterns  of  cognitive
eﬁcits  are  described  in  the  literature  (Athilingam,  D’Aoust,
iller,  &  Chen,  2013).
In  our  study,  we  assessed  memory  and  some  aspects  of
he  executive  functions.  Cognitive  performance  in  the  HF
atients  listed  for  HTx  was  signiﬁcantly  lower  than  in  the
ontrol  group  made  up  of  patients  with  stable  CHD,  without
iagnosis  of  HF,  regarding  all  tested  functions.  This  is  consis-
ent  with  previous  studies,  where  HF  patients  demonstrated
oorer  performance  compared  to  healthy  participants,  as
oncerns  memory,  psychomotor  speed  and  executive  func-
ioning  (Levin  et  al.,  2014;  Nordlund  et  al.,  2015).  More
evere  HF  was  also  associated  with  poorer  visuospatial  recall
bility  (Pressler  et  al.,  2010b),  which  was  conﬁrmed  in
ur  study.  This  cognitive  proﬁle  resembles  the  one  seen  in
‘vascular  cognitive  impairment’’,  which  includes  prominent
xecutive  dysfunction  (Jokinen  et  al.,  2006).  But  contrary
o  patients  with  vascular  cognitive  impairment,  in  the  HF
roup,  we  also  found  extensive  memory  deﬁcits.  Although
F  patients  are  at  risk  of  cerebrovascular  damage,  subcor-
ical  ischemic  vascular  disease  might  therefore  not  be  the
236  J.M.  Morys´ et  al.
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iFigure  2  The  linear  regressions  of  MNGlo
ole  explanation  for  the  observed  cognitive  changes  in  HF
atients.  The  ﬁnding  that  many  patients  with  HF  have  cog-
itive  deﬁcits  has  important  clinical  implications,  because
hese  deﬁcits  can  disrupt  their  ability  to  perform  activities
f  daily  life,  and  they  comply  with  HF  self-care  behaviours.
his  is  especially  important  in  these  patients,  because  even
inor  non-compliance  could  lead  to  acute  decompensated
eart  failure  (ADHF)  (Buck  et  al.,  2012).
There  are  data  highlighting  the  incidence  of  depression
n  patients  with  coronary  heart  disease,  showing  correla-
ions  between  depression  and  mortality  in  patients  with
ocumented  CHD,  and  between  depression  and  mortality
n  populations  with  and  without  CHD  (Dimos,  Stougiannos,
akkavas,  &  Trikas,  2009).  In  our  study,  patients  who  had
een  diagnosed  by  psychiatric  assessment  with  depressive
isorders  were  excluded  from  further  study  because  of  the
mpact  of  these  disorders  on  cognitive  functions.  However,
e  found  that  the  mean  scores  in  BDI-II  were  higher  than
n  the  control  group.  This  is  consistent  with  information
rom  other  researchers,  who  indicated  a  higher  incidence  of
epression  in  patients  with  CHD  than  in  the  general  popula-
ion.  Signiﬁcant  depression  has  been  reported  in  15-22%  of
atients  who  suffer  from  cardiovascular  disease,  while  65%
f  the  same  population  show  mild  symptoms  of  depression
Carney,  Freedland,  Sheline,  &  Weiss,  1997).  In  patients  with
hronic  HF  depression  is  common,  with  a  prevalence  that
anges  from  13%  to  77%,  according  to  the  diagnostic  method
sed  and  the  characteristics  of  the  population  (Angermann
t  al.,  2011).
There  is  a  lot  of  evidence  to  suggest  that  depression
ncreases  the  risk  of  cognitive  impairment  regarding  work-
ng  memory,  attention  and  executive  dysfunction,  and
i
b
i
tnd  BDI-II,  COWAT  K,  COWAT  M,  and  CTT2.
rocessing  speed  (Doumas,  Smolders,  Brunfaut,  Bouckaert,
 Krampe,  2012).  In  our  study  we  observed  that  the
elationship  between  an  increase  in  points  in  BDI-II  and
ognitive  testing  concerns  only  the  immediate  memory  (LM
 Recall)  in  the  HF  group.  However,  in  the  cardiac  control
roup  there  was  a  relationship  between  the  results  of  BDI-II
nd  CTT1,  CTT2  and  LM  I Recall.  Numerous  studies  indicate
hat  depression  may  negatively  impact  different  types  of
emory,  including  explicit,  implicit,  short-term,  long-term
nd  working  memory  (McClintock,  Husain,  Greer,  &  Cullum,
010).  Performance  on  verbal  memory  tasks  may  result
rom  poor  frontal-temporal  lobe  functioning,  preoccupation
ith  negative  thoughts,  or  decreased  processing  speed
McClintock  et  al.,  2010).
Heart  failure  seems  to  dramatically  affect  the  quality  of
ife  in  patients,  since  their  quality  of  life  is  described  as  the
owest  compared  to  patients  with  other  chronic  disorders
Garin  et  al.,  2013;  Höfer  et  al.,  2012).  A  high  proportion
f  patients  with  advanced  HF  suffer  from  refractory  symp-
oms,  such  as  breathlessness,  persistent  cough,  fatigue,  and
imitation  in  physical  activity.  In  addition,  many  patients  suf-
er  from  pain,  anxiety,  depression,  nausea  and  constipation
Jaarsma,  Johansson,  Agren,  &  Stromberg,  2010).  Quality  of
ife  measures  are  useful  when  interventions  or  treatments
re  indicated  for  several  reasons,  such  as  improvement  of
hysical  functioning,  pain  relief,  to  estimate  the  effective-
ess  of  therapies,  and  to  predict  mortality.  Our  research
ndicates  that  there  is  a  close  correlation  between  grow-
ng  depression  scale  results  and  declining  quality  of  life,
oth  global  and  in  all  its  dimensions  in  the  HF  group.  This
s  consistent  with  the  data  available  in  the  scientiﬁc  litera-
ure  (Gathright  et  al.,  2015;  Hwang,  Liao,  &  Huang,  2013).
Cognitive  impairment,  symptoms  of  depression,  and  health-relat
Table  5  Analysis  of  the  relationship  between  the  results  of
the symptoms  of  depression  and  tests  of  cognitive  functions
as well  as  quality  of  life  in  the  heart  failure  group.
HF  group  Control  group
BDI-II
MMSE  .05  .16
COWAT  K  -.24  .24
COWAT  Z  -.11  .07
COWAT  M  -.00  -.10
Digit Span  forward  .05  .14
Digit Span backward -.07 .09
CTT1  .11 -.38**
CTT2  .04 -.34*
Spatial  span  -forward  -.11  .17
Spatial  span  -backward  -.04  .28*
LM  I  Recall  -.32* .42***
LM  II  Recall  -.27  -.26
LM II  Recognition  -.09  -.11
LM II  %  Retention  -.01  .05
CVLT-TL  -.08  -.14
CVLT-SDFR  .02  -.10
CVLT-SDCR  -.04  -.21
CVLT-LDFR  -.09  -.20
CVLT-LDCR  .00  -.23
CVLT-recognition  -.02  -.18
MacNew  Glob  -.47*** -.36**
MacNew  Ph  -.29* -.16
MacNew  Em  -.56*** -.13
MacNew  Sc  -.44*** -.33*
Note.
* p < .05.
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E** p < .01.
*** p < .005.
Meanwhile,  in  the  cardiac  control  group  the  results  of  BDI-II
correlated  only  with  global  and  social  QoL.  It  seems  that
this  reﬂects  the  negative  impact  of  depression  on  social
relations.  It  was  surprising  that  while  in  the  cardiac  con-
trol  group  we  observed  a  relationship  between  quality  of
life  and  executive  functions,  in  the  HF  group  there  was  no
relationship  between  quality  of  life  and  impaired  cognitive
function.  However,  there  is  a  relationship  between  quality
of  life  and  the  results  in  BDI-II  in  both  groups.  In  the  case  of
the  HF  group,  the  presence  of  depressive  symptoms  among
all  the  analysed  symptoms  is  the  only  factor  that  affects
quality  of  life.
A  major  limitation  of  the  presented  study  is  its  relatively
small  sample  size,  which  resulted  from  the  fact  that  we
aimed  at  a  high  homogeneity  group,  i.e.  patients  who  had
heart  failure  in  the  relative  absence  of  other  serious  disor-
ders  due  to  HTx  listing  that  could  affect  cognitive  function.
Additionally,  we  limited  estimation  only  to  certain  cognitive
functions.  This  was  due  to  the  high  fatigability  of  patients
and  their  poor  physical  condition.
In  conclusion,  cognitive  deﬁcits  are  a  very  common  prob-
lem  that  affects  patients  with  chronic  HF.  Memory  deﬁcits
are  the  most  common,  followed  by  psychomotor  slowing,
decreased  visuospatial  ability  and  executive  function.  This
disturbance  can  have  a  signiﬁcant  impact  on  daily  function-
ing,  and  thus  it  should  be  continually  monitored.  There  is  a
Fed  quality  of  life  237
elationship  between  the  severity  of  depressive  symptoms,
nd  the  assessment  of  the  quality  of  life  of  patients  with
eart  failure.
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